source
- Supreme Court rules generic Vascepa copy does not infringe patents, boosting skinny-label pathwayThe U.S. Supreme Court issued a decision that Hikma Pharmaceuticals’ generic version of Amarin’s heart drug Vascepa does not infringe the brand’s patents. The ruling clarified that the generic make…
- Analysts warn that PD-1/VEGF bispecific drugs may be better suited for liver cancer than lung cancerMany drugmakers have poured billions into PD-1/VEGF bispecific antibodies after ivonescimab beat Keytruda in a 2024 lung‑cancer trial, sparking a wave of deals and development programs. A recent C…